**Percutaneous Treatment of Mitral and Tricuspid Regurgitation in Heart Failure**

Tomás Benito-González, Rodrigo Estévez-Loureiro, Javier Gualis Cardona, Armando Pérez de Prado, Mario Castaño Ruiz and Felipe Fernández-Vázquez

Additional information is available at the end of the chapter

http://dx.doi.org/10.5772/intechopen.68493

#### **Abstract**

[36] Arora, R., et al., *Atrial septal defect after balloon mitral valvuloplasty: a transesophageal echo-*

[37] Cequier, A., et al., *Left-to-right atrial shunting after percutaneous mitral valvuloplasty. Incidence and long-term hemodynamic follow-up.* Circulation, 1990. **81**(4): pp. 1190-1197. [38] Fawzy, M.E., et al., *Immediate and long-term results of mitral balloon valvotomy for restenosis following previous surgical or balloon mitral commissurotomy.* The American Journal of

[39] McFaul, P., et al., *Pregnancy complicated by maternal heart disease. A review of 519 women.* BJOG: An International Journal of Obstetrics & Gynaecology, 1988. **95**(9): pp. 861-867.

[40] Zitnik, R.S., et al., *Pregnancy and open-heart surgery.* Circulation, 1969. **39**(5S1): pp.

[41] Nercolini, D.C., et al., *Percutaneous mitral balloon valvuloplasty in pregnant women with mitral stenosis.* Catheterization and Cardiovascular Interventions, 2002. **57**(3): pp. 318-322.

[42] Esteves, C.A., et al., *Immediate and long-term follow-up of percutaneous balloon mitral valvuloplasty in pregnant patients with rheumatic mitral stenosis.* The American Journal of

[43] Nobuyoshi, M., et al., *Indications, complications, and short-term clinical outcome of percutane-*

[44] Iung, B., et al., *Immediate results of percutaneous mitral commissurotomy a predictive model on* 

*ous transvenous mitral commissurotomy.* Circulation, 1989. **80**(4): pp. 782-792.

*a series of 1514 patients.* Circulation, 1996. **94**(9): pp. 2124-2130.

*cardiographic study.* Angiology, 1993. **44**(3): pp. 217-221.

Cardiology, 2005. **96**(7): pp. 971-975.

Cardiology, 2006. **98**(6): pp. 812-816.

I-257–I-262.

116 Interventional Cardiology

Heart failure has become a real epidemic condition related to poor outcomes despite advances in medical therapies. Prevalence of significant mitral and/or tricuspid regurgitation is high in patients with advanced heart failure. Novel transcatheter techniques have recently emerged as a minimally invasive alternative in patients deemed high-risk for surgery or inoperable. Among them, MitraClip® system is thus far the first device that received regulatory approval and gained widespread clinical application, especially in patients with functional mitral regurgitation. Furthermore, first experiences with new devices for percutaneous mitral and tricuspid valves repair, and transcatheter mitral valve prosthesis have been increasingly reported. Percutaneous therapies for valvular heart disease have therefore become one of the most promising fields in the present and future of interventional cardiology and heart failure.

**Keywords:** mitral valve, tricuspid valve, advanced heart failure, MitraClip®, percutaneous edge-to-edge mitral valve repair, Cardioband®, Mitralign®, Carillon®, percutaneous tricuspid valve repair, transcatheter mitral valve prosthesis
